IVI will host two upcoming webinars focused on its new disease-specific, open-source value model to assess EGFR+ non-small cell lung cancer (NSCLC) therapy sequences. These webinars are free and open to the public. We hope [...]
IVI released our initial version of the new Open-Source Value Platform (OSVP) model for non-small cell lung cancer. Specifically, the model provides information on the relative value of sequential treatments for epidermal growth factor receptor [...]
In a Morning Consult commentary, IVI Executive Director, Jennifer Bright, discusses why transparency is a prerequisite to value-based reimbursement and how IVI's Open-Source Value Platform (OSVP) is an open laboratory for creating sophisticated systems to assess [...]
In an article published online by the American Journal of Managed Care, IVI's Executive Director, Jennifer Bright, and Director of Scientific Communications, Mark Linthicum, offer five predictions for where value assessment is headed in 2019. [...]
IVI research into six pre-2016 ICER studies reveals an overestimation of “unmanaged” drug use and drug cost trends. The peer-reviewed research, published in Value in Health, illustrates the difficulty in predicting budget impact and the [...]
Value Frameworks Must Incorporate Real-World Evidence, Says Research Team Including IVI’s Darius Lakdawalla and Wayne Burton
In a new paper published by the American Journal of Managed Care, a team of researchers, including IVI's Darius Lakdawalla and Wayne Burton, conclude that key decision makers within our healthcare system need to recognize [...]
In an interview with the Journal of Clinical Pathways, IVI's Jennifer Bright and Mark Linthicum discuss how IVI is transforming value assessment. Read the transcript from the interview here.
In an article published on AJMC.com, IVI'sJennifer Bright discusses how IVI makes incorporating patients' perspectives a priority in developing open-source, transparent value models. Read the full article here.
PRESS RELEASE: IVI’s Patient Research Reveals Importance of Quality of Life in Assessing Non-Small Cell Lung Cancer Therapy Sequence Value
Los Angeles, CA – November 15, 2018 – The Innovation and Value Initiative (IVI) – a nonprofit dedicated to advancing the science and improving the practice of value assessment in healthcare – today released qualitative [...]
IVI has released the results to their non-small cell lung cancer patient qualitative research, which was used in the development of the structure of upcoming OSVP designed to evaluate lung cancer therapy sequences. According to [...]
IVI economists showcased the results of multiple research streams supporting open-source value modeling initiative at the leading European conference for health economics and outcomes research. Presentation topics included: Development of open-source software for conducting value [...]
PRESS RELEASE: IVI Showcases Recent Research Activities as Part of the Open-Source Value Project at ISPOR EU 2018
Los Angeles, CA – November 13, 2018 – The Innovation and Value Initiative (IVI) – a collaboration dedicated to advancing the science and improving the practice of value assessment in healthcare – will present research [...]